BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sandhir R, Gupta S. Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal. World J Diabetes 2015; 6(12): 1223-1242 [PMID: 26464760 DOI: 10.4239/wjd.v6.i12.1223]
URL: https://www.wjgnet.com/1007-9327/full/v6/i12/1223.htm
Number Citing Articles
1
Lütfiye Özpak, Ayfer Pazarbasi, Işıl Öcal, M. Bertan Yılmaz, Hülya Binokay. Investigation of extracellular matrix genes associated with Alzheimer’s disease in the hippocampus of experimental diabetic model ratsInternational Journal of Diabetes in Developing Countries 2022; 42(1): 82 doi: 10.1007/s13410-021-00951-7
2
Iwona Piątkowska-Chmiel, Mariola Herbet, Monika Gawrońska-Grzywacz, Kamil Pawłowski, Marta Ostrowska-Leśko, Jarosław Dudka. Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic micePsychopharmacology 2023; 240(4): 983 doi: 10.1007/s00213-023-06341-7
3
Joanna Wojsiat, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, Urszula Wojda. Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic ProspectsOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/6435861
4
Jorge Berlanga-Acosta, Gerardo Guillén-Nieto, Nadia Rodríguez-Rodríguez, Maria Luisa Bringas-Vega, Diana García-del-Barco-Herrera, Jorge O. Berlanga-Saez, Ariana García-Ojalvo, Mitchell Joseph Valdés-Sosa, Pedro A. Valdés-Sosa. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A ReviewFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.560375
5
Maria Rosaria Rizzo, Irene Di Meo, Rita Polito, Maria Chiara Auriemma, Antonio Gambardella, Gabriella di Mauro, Annalisa Capuano, Giuseppe Paolisso. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatmentPharmacological Research 2022; 176: 106062 doi: 10.1016/j.phrs.2022.106062
6
Lin Li. The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin PathwayCNS Drugs 2017; 31(7): 535 doi: 10.1007/s40263-017-0431-2
7
Umit Cintosun, Mehmet I. Naharci, Huseyin Doruk. Defining Randomly Measured Glycemic Values As a Risk Factor for Dementia: Accurate and Adequate?Journal of the American Geriatrics Society 2016; 64(9): 1925 doi: 10.1111/jgs.14192
8
Rohit Pardeshi, Nityanand Bolshette, Kundlik Gadhave, Ashutosh Ahire, Sahabuddin Ahmed, Tommaso Cassano, Veer Bala Gupta, Mangala Lahkar. Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s diseasePsychoneuroendocrinology 2017; 83: 159 doi: 10.1016/j.psyneuen.2017.05.004
9
Smriti Gupta, Vishal Singh, Subramaniam Ganesh, Nitin K. Singhal, Rajat Sandhir. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer’s Disease Pathology: Evidence from In Vitro and In Vivo StudiesACS Applied Materials & Interfaces 2022; 14(1): 69 doi: 10.1021/acsami.1c15305
10
Smriti Gupta, Nitin Kumar Singhal, Subramaniam Ganesh, Rajat Sandhir. Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic TargetsCNS & Neurological Disorders - Drug Targets 2019; 18(3): 172 doi: 10.2174/1871527317666181114163515
11
Nimona Ashebir, Hailemariam Hailesilassie, Shimelis Girma, Elias Nigusu, Elias Ezo. Prevalence of Cognitive Impairment and Associated Factors Among Diabetes Mellitus Patients Attending Follow-up Treatment at Fiche General Hospital, North EthiopiaSAGE Open Nursing 2024; 10 doi: 10.1177/23779608241227752
12
Milagros Rojas, Mervin Chávez-Castillo, Jordan Bautista, Ángel Ortega, Manuel Nava, Juan Salazar, Edgar Díaz-Camargo, Oscar Medina, Joselyn Rojas-Quintero, Valmore Bermúdez. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics linksWorld Journal of Diabetes 2021; 12(6): 745-766 doi: 10.4239/wjd.v12.i6.745
13
Yu Song, Shanshan Chen, Ju Gao, Jie Lu, Wenwen Xu, Xingjian Lin, Jiu Chen. Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's DiseaseFrontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.673347
14
Y. Shi, X. Sun, Y. Sun, L. Hou, M. Yao, K. Lian, J. Li, X. Lu, L. Jiang. Elevation of cortical C26:0 due to the decline of peroxisomal β-oxidation potentiates amyloid β generation and spatial memory deficits via oxidative stress in diabetic ratsNeuroscience 2016; 315: 125 doi: 10.1016/j.neuroscience.2015.11.067
15
Aikaterini Trikkalinou, Athanasia K Papazafiropoulou, Andreas Melidonis. Type 2 diabetes and quality of lifeWorld Journal of Diabetes 2017; 8(4): 120-129 doi: 10.4239/wjd.v8.i4.120
16
Varda Shoshan-Barmatz, Edna Nahon-Crystal, Anna Shteinfer-Kuzmine, Rajeev Gupta. VDAC1, mitochondrial dysfunction, and Alzheimer's diseasePharmacological Research 2018; 131: 87 doi: 10.1016/j.phrs.2018.03.010
17
Luis Jesuino de Oliveira Andrade, Luís Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, Letícia Góes de Carvalho Lourenço, Gabriela Correia Matos de Oliveira. Brain insulin resistance and Alzheimer’s disease: a systematic reviewDementia & Neuropsychologia 2024; 18 doi: 10.1590/1980-5764-dn-2023-0032
18
J. Mendiola-Precoma, L. C. Berumen, K. Padilla, G. Garcia-Alcocer. Therapies for Prevention and Treatment of Alzheimer’s DiseaseBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/2589276
19
Ming-Min Chung, Christopher J. Nicol, Yi-Chuan Cheng, Kuan-Hung Lin, Yen-Lin Chen, Dee Pei, Chien-Hung Lin, Yi-Nuo Shih, Chia-Hui Yen, Shiang-Jiuun Chen, Rong-Nan Huang, Ming-Chang Chiang. Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCsExperimental Cell Research 2017; 352(1): 75 doi: 10.1016/j.yexcr.2017.01.017
20
Smriti Gupta, Kamalendra Yadav, Shrikant S. Mantri, Nitin K. Singhal, Subramaniam Ganesh, Rajat Sandhir. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s DiseaseMolecular Neurobiology 2018; 55(12): 8916 doi: 10.1007/s12035-018-0985-0
21
R. Loera‐Valencia, A. Cedazo‐Minguez, P.A. Kenigsberg, G. Page, A.I. Duarte, P. Giusti, M. Zusso, P. Robert, G. B. Frisoni, Annamaria Cattaneo, M. Zille, J. Boltze, N. Cartier, L. Buee, G. Johansson, B. Winblad. Current and emerging avenues for Alzheimer's disease drug targetsJournal of Internal Medicine 2019; 286(4): 398 doi: 10.1111/joim.12959
22
André Quincozes-Santos, Larissa Daniele Bobermin, Adriano M. de Assis, Carlos-Alberto Gonçalves, Diogo Onofre Souza. Fluctuations in glucose levels induce glial toxicity with glutamatergic, oxidative and inflammatory implicationsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(1): 1 doi: 10.1016/j.bbadis.2016.09.013
23
John M. Hickey, Neha Sahni, Rajoshi Chaudhuri, Ajit D'Souza, Andrew Metters, Sangeeta B. Joshi, C. Russell Middaugh, David B. Volkin. Effect of acrylodan conjugation and forced oxidation on the structural integrity, conformational stability, and binding activity of a glucose binding protein SM4 used in a prototype continuous glucose monitorProtein Science 2017; 26(3): 527 doi: 10.1002/pro.3102
24
Mohammad Zubair, Farha Fatima, Fohad Mabood Husain. Current Thoughts on Dementia2022; : 273 doi: 10.1007/978-981-16-7606-2_11
25
Patrizia Mecocci, Virginia Boccardi, Roberta Cecchetti, Patrizia Bastiani, Michela Scamosci, Carmelinda Ruggiero, Marta Baroni, George Perry, Jesus Avila, Massimo Tabaton, Xiongwei Zhu. A Long Journey into Aging, Brain Aging, and Alzheimer’s Disease Following the Oxidative Stress TracksJournal of Alzheimer's Disease 2018; 62(3): 1319 doi: 10.3233/JAD-170732
26
Ting-I Chiang, Yi-Hsiang Yu, Chieh-Hsin Lin, Hsien-Yuan Lane. Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative StressClinical Psychopharmacology and Neuroscience 2021; 19(3): 423 doi: 10.9758/cpn.2021.19.3.423
27
Tian Li, Juan‐Juan Jiao, Christian Hölscher, Mei‐Na Wu, Jun Zhang, Jia‐Qing Tong, Xue‐Fan Dong, Xue‐Song Qu, Yue Cao, Hong‐Yan Cai, Qiang Su, Jin‐Shun Qi. A novel GLP‐1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's diseaseHippocampus 2018; 28(5): 358 doi: 10.1002/hipo.22837
28
Zhike Zhou, Jun Bai, Shanshan Zhong, Rongwei Zhang, Kexin Kang, Xiaoqian Zhang, Ying Xu, Chuansheng Zhao, Mei Zhao, Fabiana Morroni. Downregulation of PIK3CB Involved in Alzheimer’s Disease via Apoptosis, Axon Guidance, and FoxO Signaling PathwayOxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/1260161
29
Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Rashmi K. Ambasta, Pravir Kumar. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in NeurodegenerationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(5): 1132 doi: 10.1016/j.bbadis.2016.06.015
30
Sebastian Bertram, Klara Brixius, Christian Brinkmann. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patientsEndocrine 2016; 53(2): 350 doi: 10.1007/s12020-016-0976-8
31
Tapan Behl, Arpita Arora, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harrasi, Simona Bungau, Ebrahim Mostafavi. Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and DementiaCNS & Neurological Disorders - Drug Targets 2022; 21(7): 542 doi: 10.2174/1871527320666211110115257
32
Michael R. D’Andrea. Intracellular Consequences of Amyloid in Alzheimer's Disease2016; : 155 doi: 10.1016/B978-0-12-804256-4.00008-5
33
Brett D. Story, Matthew E. Miller, Allison M. Bradbury, Emily D. Million, Dongsheng Duan, Toloo Taghian, Dominik Faissler, Deborah Fernau, Sidney J. Beecy, Heather L. Gray-Edwards. Canine Models of Inherited Musculoskeletal and Neurodegenerative DiseasesFrontiers in Veterinary Science 2020; 7 doi: 10.3389/fvets.2020.00080